INSERM INST NAT DE LA SANTE ET DE LA RECH MEDICALE has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ONCOLYS BIOPHARMA INC, CHILDRENS HOSPITAL INC and TRANSGENE SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 12 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Special foods | |
#7 | Foods | |
#8 | Heterocyclic compounds | |
#9 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Anegon Ignacio | 2 |
#2 | Guillonneau Carole | 2 |
#3 | Bezie Severine | 2 |
#4 | Sergeant Nicolas | 1 |
#5 | Dechelotte Pierre | 1 |
#6 | Favre Gilles | 1 |
#7 | Arce-Gorvel Vilma | 1 |
#8 | Bery Nicolas | 1 |
#9 | Nguyen Tuan Huy | 1 |
#10 | De Masson Adele | 1 |
Publication | Filing date | Title |
---|---|---|
CN108699154A | There is the antibody and application thereof of specificity to BTLA | |
CN108026176A | For strengthening the method and pharmaceutical composition of NK cell killing activities | |
CN106574235A | Modified bacteria for improved vaccines against brucellosis | |
CN106999545A | The medicine and food composition of full sense are satiated with food and extended for being induced in subject in need |